TES and SLC40A1 as potential biomarkers for predicting survival in T-cell acute lymphoblastic leukemia. Zeng X, Liu K, Xu R, Zhang L, et al. Acta Haematol 2024 May 28. doi: 10.1159/000539435.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zeng X, Liu K, Xu R, Zhang L, et al. TES and SLC40A1 as potential biomarkers for predicting survival in T-cell acute lymphoblastic leukemia. Acta Haematol 2024 May 28. doi: 10.1159/000539435.
PMID: 38806013